Bocouture®/Xeomin® injections for the elimination of facial wrinkles and treatment of hyperhidrosis from the Merz, Germany
-
- Bocouture®/Xeomin® – the most modern botulinum therapy drug differs from other toxins with a higher degree of purification, it is a natural toxin
- Bocouture® is the purest botulinum toxin type A.
- Bocouture® is the most recommended drug for allergy sufferers.
Advantages of Bocouture®
Bocouture® contains a pure neurotoxin because it lacks immunogenic bacterial proteins (so-called complexing proteins).
The presence of these proteins in other botulinum toxin type A drugs has no therapeutic properties. This only unnecessarily complicates the functioning of the immune system, which leads to the ineffectiveness of repeated treatment.
According to research, even repeated administration of high doses of Bocouture® does not cause the formation of antibodies.
The results of treatment with Bocouture® can be seen after a day, and its effect lasts up to 4 months.
Currently, Bocouture® is the most recommended drug for allergy sufferers who are allergic to proteins and people who are regularly treated with botulinum toxin type A.
The mechanism of action of Bocouture®
Bocouture is injected into the facial muscles. The drug blocks nerve signals that reach the muscles and cause them to contract. As a result, the facial muscles stop contracting and provoke the formation of wrinkles.
At the same time, the face does not become sedentary, and facial expressions are preserved. When using Bocouture, only those muscles that cause the formation of facial wrinkles relax. The underlying muscles are not affected. It is these muscles that provide a lively facial expression, and in the case of using Bocouture®, they do not suffer.
Due to this, the face retains its natural expression, facial expressions, mobility, and the ability to express emotions. This explains the choice in favor of Bocouture for those who would like to look younger, get rid of facial wrinkles, do a facelift, and at the same time maintain full mobility.
The drug can also suppress the secretion of sweat glands.
Like all type A botulinum toxins (Botox/Vistabel, Disport, etc.) Bocouture® is not a rejuvenating agent. It does not activate collagen production or create a supportive framework. Other treatments in our Clinic do that. It simply gives the face a rest.
Bocouture® relaxes the facial muscles around the eyes and on the forehead. Thanks to this, the formation of expression lines stops. Moreover, existing wrinkles are smoothed out. The face is restored.
Externally, this process looks like rejuvenation. But essentially it is just a facial rest. The wrinkle-smoothing effect is achieved by perfect muscle relaxation.
Indications for the use of Bocouture
Bocouture® effectively eliminates the entire complex of facial wrinkles, including:
- vertical and horizontal wrinkles on the forehead;
- “crow’s feet” and other fine lines around the eyes;
- superficial wrinkles in the eyebrow area and between the eyebrows (on the bridge of the nose).
An additional indication is hyperhidrosis (increased sweating).
Description of the Bocouture treatment
The treatment is almost completely painless, but in the case of patients who are particularly sensitive to pain, you can use the anesthetic cream “Emla”.
Bocouture® is injected into the muscle with a thin disposable needle, usually, several punctures are made for a given muscle – the specific number depends on the location on the face and the doctor’s indication.
Effect
- Smoothing horizontal wrinkles on the forehead.
- Smoothing wrinkles between the eyebrows.
- Smoothing the lower eyelid and increasing the volume of the eyes.
- Smoothes the so-called “crow’s feet” raises eyebrows.
- Smoothes rabbit wrinkles on the nose.
Possibly there may be redness or swelling at the puncture sites.
Contraindications
- Pregnancy and lactation.
- Oncology.
- Allergy to albumin.
- Blood clotting disorders.
- Taking substances that interfere with blood clotting (e.g. coumarin, heparin, Acetylsalicylic acid, clopidogrel).
- Allergy to botulinum type A or to any other component of this drug.
- Before surgical intervention.
- Children and adolescents under the age of 18 years.
- Muscle activity disorders (myasthenia gravis, Lambert-Eaton syndrome).
- Epilepsy.
- Disorders of the nervous system.
- Infection or inflammation at the intended injection site.
Photos before and after application of Bocouture®
